‘Miracle drug’ can cost Rs 13 lakh for haemophilia A patient annually, but reduced dose found efficacious & cost-effective in small trial. Larger trial is under way.
Studies in The Lancet & The Lancet Haematology show 1st of its kind preventive therapy by Sanofi, using monthly injection 'fitusiran', can reduce bleeding in haemophilia A or B patients.
Hemgenix, manufactured by Australia's CSL Behring, is a one-time therapy, given through a single dose of IV infusion & was approved by US Food and Drug Administration this week.
The ISA should champion a Global Solar Asset Registry for standardised project information, and establish a Solar Credit Guarantee mechanism to mitigate political and currency risks.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
BJP has no dynastic succession, at least not at the top. You can trace this back to Vajpayee-Advani era. This act of spotting, empowering younger talent is even more striking with the choice of BJP presidents.
COMMENTS